Does Structured Reporting Improve Lung Cancer Reports?

• by Andrea Surnit

• July 2, 2026

ACS report: Lung cancer deaths plunge as survival doubles

Lung cancer deaths fell by more than half among US males as smoking declined, earlier-stage diagnoses increased, and 5-year relative survival doubled.

• by Andrea Surnit

• September 28, 2026

• 6 min

FDA approves serial liquid biopsy testing

In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.

• by Kathryn Wighton

• September 8, 2026

• 2 min

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

• by Kathryn Wighton

• August 10, 2026

• 1 min